About
Technology
Issues
FAQ
Search
Scientometrics
Impact Factor
Discipline Ranks
h
-index
g
-index
Articles
Citations
Article Citations
Citation Distribution
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Journals
›
Neurology: Neuroimmunology and NeuroInflammation
›
top-articles
Neurology: Neuroimmunology and NeuroInflammation
6.7
(top 5%)
impact factor
1.1K
(top 20%)
papers
28.6K
(top 10%)
citations
75
(top 10%)
h
-index
6.9
(top 5%)
impact factor
1.3K
all documents
31.8K
doc citations
110
(top 10%)
g
-index
Top Articles
#
Title
Journal
Year
Citations
1
MOG antibody–positive, benign, unilateral, cerebral cortical encephalitis with epilepsy
Neurology: Neuroimmunology and NeuroInflammation
2017
334
2
MOG cell-based assay detects non-MS patients with inflammatory neurologic disease
Neurology: Neuroimmunology and NeuroInflammation
2015
322
3
Updated Diagnostic Criteria for Paraneoplastic Neurologic Syndromes
Neurology: Neuroimmunology and NeuroInflammation
2021
313
4
Guillain-Barré syndrome related to COVID-19 infection
Neurology: Neuroimmunology and NeuroInflammation
2020
288
5
Does MOG Ig-positive AQP4-seronegative opticospinal inflammatory disease justify a diagnosis of NMO spectrum disorder?
Neurology: Neuroimmunology and NeuroInflammation
2015
242
6
Myelin oligodendrocyte glycoprotein antibodies are associated with a non-MS course in children
Neurology: Neuroimmunology and NeuroInflammation
2015
205
7
Rituximab in treatment-resistant CIDP with antibodies against paranodal proteins
Neurology: Neuroimmunology and NeuroInflammation
2015
205
8
Antibodies to MOG in adults with inflammatory demyelinating disease of the CNS
Neurology: Neuroimmunology and NeuroInflammation
2015
203
9
Guillain-Barré syndrome: The first documented COVID-19–triggered autoimmune neurologic disease
Neurology: Neuroimmunology and NeuroInflammation
2020
201
10
Antibodies to myelin oligodendrocyte glycoprotein in bilateral and recurrent optic neuritis
Neurology: Neuroimmunology and NeuroInflammation
2014
192
11
International multicenter examination of MOG antibody assays
Neurology: Neuroimmunology and NeuroInflammation
2020
180
12
Autoantibodies to MOG in a distinct subgroup of adult multiple sclerosis
Neurology: Neuroimmunology and NeuroInflammation
2016
178
13
Clinical approach to the diagnosis of autoimmune encephalitis in the pediatric patient
Neurology: Neuroimmunology and NeuroInflammation
2020
178
14
Early CNS neurodegeneration in radiologically isolated syndrome
Neurology: Neuroimmunology and NeuroInflammation
2015
177
15
Aquaporin-4 autoimmunity
Neurology: Neuroimmunology and NeuroInflammation
2015
173
16
Apheresis therapies for NMOSD attacks
Neurology: Neuroimmunology and NeuroInflammation
2018
173
17
IgLON5 antibody
Neurology: Neuroimmunology and NeuroInflammation
2017
172
18
Reduction of CD8
+
T lymphocytes in multiple sclerosis patients treated with dimethyl fumarate
Neurology: Neuroimmunology and NeuroInflammation
2015
171
19
COVID-19-related acute necrotizing encephalopathy with brain stem involvement in a patient with aplastic anemia
Neurology: Neuroimmunology and NeuroInflammation
2020
165
20
Basal ganglia T1 hyperintensity in LGI1-autoantibody faciobrachial dystonic seizures
Neurology: Neuroimmunology and NeuroInflammation
2015
163
21
Acute disseminated encephalomyelitis after SARS-CoV-2 infection
Neurology: Neuroimmunology and NeuroInflammation
2020
163
22
Rituximab before and during pregnancy
Neurology: Neuroimmunology and NeuroInflammation
2018
159
23
Antibodies to MOG have a demyelination phenotype and affect oligodendrocyte cytoskeleton
Neurology: Neuroimmunology and NeuroInflammation
2014
158
24
Effects of neuromyelitis optica–IgG at the blood–brain barrier in vitro
Neurology: Neuroimmunology and NeuroInflammation
2017
153
25
Abnormal brain metabolism on FDG-PET/CT is a common early finding in autoimmune encephalitis
Neurology: Neuroimmunology and NeuroInflammation
2017
146
26
Next-generation sequencing in neuropathologic diagnosis of infections of the nervous system
Neurology: Neuroimmunology and NeuroInflammation
2016
142
27
P2Y12 expression and function in alternatively activated human microglia
Neurology: Neuroimmunology and NeuroInflammation
2015
139
28
Neuroleptic intolerance in patients with anti-NMDAR encephalitis
Neurology: Neuroimmunology and NeuroInflammation
2016
139
29
Neuromyelitis optica spectrum disorders
Neurology: Neuroimmunology and NeuroInflammation
2016
134
30
Does time equal vision in the acute treatment of a cohort of AQP4 and MOG optic neuritis?
Neurology: Neuroimmunology and NeuroInflammation
2019
133
31
B lymphocytes in neuromyelitis optica
Neurology: Neuroimmunology and NeuroInflammation
2015
132
32
COVID-19 outcomes in MS
Neurology: Neuroimmunology and NeuroInflammation
2020
130
33
Systemic inflammatory response and neuromuscular involvement in amyotrophic lateral sclerosis
Neurology: Neuroimmunology and NeuroInflammation
2016
129
34
Increased frequency of anti-Ma2 encephalitis associated with immune checkpoint inhibitors
Neurology: Neuroimmunology and NeuroInflammation
2019
129
35
Microstructural visual system changes in AQP4-antibody–seropositive NMOSD
Neurology: Neuroimmunology and NeuroInflammation
2017
128
36
Both cladribine and alemtuzumab may effect MS via B-cell depletion
Neurology: Neuroimmunology and NeuroInflammation
2017
121
37
Neurofilament light in CSF and serum is a sensitive marker for axonal white matter injury in MS
Neurology: Neuroimmunology and NeuroInflammation
2016
118
38
The topographical model of multiple sclerosis
Neurology: Neuroimmunology and NeuroInflammation
2016
118
39
Antibodies to neurofascin, contactin-1, and contactin-associated protein 1 in CIDP
Neurology: Neuroimmunology and NeuroInflammation
2020
118
40
Dimethyl fumarate treatment alters circulating T helper cell subsets in multiple sclerosis
Neurology: Neuroimmunology and NeuroInflammation
2016
117
41
Expanded autologous regulatory T-lymphocyte infusions in ALS
Neurology: Neuroimmunology and NeuroInflammation
2018
116
42
Clinical utility of testing AQP4-IgG in CSF
Neurology: Neuroimmunology and NeuroInflammation
2016
113
43
Interleukin-6 in neuromyelitis optica spectrum disorder pathophysiology
Neurology: Neuroimmunology and NeuroInflammation
2020
112
44
Randomized phase I trials of the safety/tolerability of anti-LINGO-1 monoclonal antibody BIIB033
Neurology: Neuroimmunology and NeuroInflammation
2014
111
45
Anti–SARS-CoV-2 antibodies in the CSF, blood-brain barrier dysfunction, and neurological outcome
Neurology: Neuroimmunology and NeuroInflammation
2020
110
46
Neurologic syndromes related to anti-GAD65
Neurology: Neuroimmunology and NeuroInflammation
2020
110
47
No evidence for higher risk of cancer in patients with multiple sclerosis taking cladribine
Neurology: Neuroimmunology and NeuroInflammation
2015
109
48
Neurofilament light chain predicts disease activity in relapsing-remitting MS
Neurology: Neuroimmunology and NeuroInflammation
2018
107
49
COVID-19-associated acute necrotizing myelitis
Neurology: Neuroimmunology and NeuroInflammation
2020
107
50
Anti-NMDAR encephalitis
Neurology: Neuroimmunology and NeuroInflammation
2020
106
site/software ©
exaly
; All materials licenced under
CC by-SA
.